TY - JOUR
T1 - Biopsychosocial factors associated with pain in veterans with the hepatitis C virus
AU - Morasco, Benjamin J.
AU - Lovejoy, Travis I.
AU - Turk, Dennis C.
AU - Crain, Aysha
AU - Hauser, Peter
AU - Dobscha, Steven K.
N1 - Funding Information:
Research reported in this manuscript was supported by grant K23DA023467 from the National Institute on Drug Abuse of the National Institutes of Health. The work was also supported with resources and the use of facilities at the Portland VA Medical Center. No author reports having any potential conflict of interest with this study. The authors appreciate the assistance of Lynsey Lewis, Susan Gritzner, and Renee Cavanagh with data collection, and Jonathan Duckart, MPS, for extracting data from the electronic medical record. We are also thankful for collaborations with Dr. G. Alan Marlatt, who assisted in the initial planning of this study. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the National Institute on Drug Abuse.
Publisher Copyright:
© 2013, Springer Science+Business Media New York (outside the USA).
PY - 2014/10
Y1 - 2014/10
N2 - Little research has examined etiological factors associated with pain in patients with the hepatitis C virus (HCV). The purpose of this study was to evaluate the relationship between biopsychosocial factors and pain among patients with HCV. Patients with HCV and pain (n = 119) completed self-report measures of pain, mental health functioning, pain-specific psychosocial variables (pain catastrophizing, self-efficacy for managing pain, social support), prescription opioid use, and demographic characteristics. In multivariate models, biopsychosocial factors accounted for 37 % of the variance in pain severity and 56 % of the variance in pain interference. In adjusted models, factors associated with pain severity include pain catastrophizing and social support, whereas variables associated with pain interference were age, pain intensity, prescription opioid use, and chronic pain self-efficacy (all p values <0.05). The results provide empirical support for incorporating the biopsychosocial model in evaluating and treating chronic pain in patients with HCV.
AB - Little research has examined etiological factors associated with pain in patients with the hepatitis C virus (HCV). The purpose of this study was to evaluate the relationship between biopsychosocial factors and pain among patients with HCV. Patients with HCV and pain (n = 119) completed self-report measures of pain, mental health functioning, pain-specific psychosocial variables (pain catastrophizing, self-efficacy for managing pain, social support), prescription opioid use, and demographic characteristics. In multivariate models, biopsychosocial factors accounted for 37 % of the variance in pain severity and 56 % of the variance in pain interference. In adjusted models, factors associated with pain severity include pain catastrophizing and social support, whereas variables associated with pain interference were age, pain intensity, prescription opioid use, and chronic pain self-efficacy (all p values <0.05). The results provide empirical support for incorporating the biopsychosocial model in evaluating and treating chronic pain in patients with HCV.
KW - Biopsychosocial model
KW - Chronic pain
KW - Hepatitis C
UR - http://www.scopus.com/inward/record.url?scp=84890006049&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890006049&partnerID=8YFLogxK
U2 - 10.1007/s10865-013-9549-y
DO - 10.1007/s10865-013-9549-y
M3 - Article
C2 - 24338521
AN - SCOPUS:84890006049
VL - 37
SP - 902
EP - 911
JO - Journal of Behavioral Medicine
JF - Journal of Behavioral Medicine
SN - 0160-7715
IS - 5
ER -